Re:Compass Pathways' Phase IIb psilocybin trial shows reduce...
by rory on Wednesday November 10, 2021 @11:31AM
(#29176587)
21% delta in remission rate vs. placebo is higher than both SSRIs and bupropion in this study [0] for example (11% for both). This is also a single dose which is amazing.
[0] https://pubmed.ncbi.nlm.nih.gov/16086611/